Impact of chemotherapy on expiratory muscle strength in stage 1 head and neck cancer patients

Yashshree J. Shindikar; Abhijit D. Diwate; Arijit K. Das

doi:10.18203/2394-6040.ijcmph20240291

Authors

Yashshree J. Shindikar Department of Cardiovascular and Respiratory Physiotherapy, DVVPF’s College of Physiotherapy, Ahmednagar, Maharashtra, India
Abhijit D. Diwate Department of Cardiovascular and Respiratory Physiotherapy, DVVPF’s College of Physiotherapy, Ahmednagar, Maharashtra, India
Arijit K. Das Department of Cardiovascular and Respiratory Physiotherapy, DVVPF’s College of Physiotherapy, Ahmednagar, Maharashtra, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20240291

Keywords:

Head and neck cancer, Stage 1 cancer, Chemotherapy, Maximum expiratory pressure

Abstract

Head and neck cancer (HNC), in current days, is one of the fatal diseases. Chemotherapy is one of the main treatments for cancer. Chemotherapy has an adverse impact on the respiratory parameters of patients. In these patients, expiratory force-generating capacity is impaired, which usually helps the patients cough effectively for airway clearance. Thus, as an impact of chemotherapy, airway clearance is affected in HNC patients. This study aimed to evaluate the impact of chemotherapy expiratory muscle strength in stage 1 head and neck cancer patients. We conducted an observational study including 15 patients with stage 1 HNC in the department of oncology in a tertiary care teaching hospital. The outcome measure included assessment of the expiratory muscle strength by measuring maximum expiratory pressure. In our study, we found a result showing a significant decline of 53.43% in maximum expiratory pressure values after 3-6 months of required chemotherapy sessions. The results of the current study suggest that chemotherapy has a deleterious impact on the expiratory muscle strength in stage 1 HNC patients after long-term exposure.

Metrics

Metrics Loading ...

References

National Cancer Institute. What is cancer? National Cancer Institute. 2021. Available at: https://www. cancer.gov/about-cancer/understanding/what-is-cancer. Accessed on 09 October 2023.

National Cancer Institute. Head and Neck Cancers. National Cancer Institute. 2021. Available at: https://www.cancer.gov/types/head-and-neck/head-neck-fact-sheet. Accessed on 09 October 2023.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49.

Prabhash K, Babu G, Chaturvedi P, Kuriakose M, Birur P, Anand AK, et al. Indian clinical practice consensus guidelines for the management of squamous cell carcinoma of head and neck. Indian J Cancer. 2020;57(5):1.

Shah JP, Montero PH. New AJCC/UICC staging system for head and neck, and thyroid cancer. Revista Médica Clínica Las Condes. 2018;29(4):397-404.

Cancer Staging. www.cancer.org. Available at: https://www.cancer.org/cancer/diagnosis-staging/staging.html. Accessed on 09 October 2023.

Behranvand N, Nasri F, Zolfaghari Emameh R, Khani P, Hosseini A, Garssen J, et al. Chemotherapy: a double-edged sword in cancer treatment. Cancer Immunol Immunotherap. 2021;71(3):507-26.

Hutcheson KA, Barrow MP, Warneke CL, Wang Y, Eapen G, Lai SY, et al. Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors. Laryngoscope. 2018;128(7):1615-21.

Nakano J, Ishii S, Fukushima T, Natsuzako A, Sakamoto J, Okita M. Factors affecting muscle strength in cancer patients receiving chemotherapy. J Novel Physiotherap Rehab. 2017;1(2):056-66.

ATS/ERS Statement on Respiratory Muscle Testing. Am J Resp Crit Care Med. 2002;166(4):518-624.

D'souza M, Samuel S, Rai S, Krishna Alaparthi G, Saxena P, Nagaraja R. Diaphragm thickness, mobility and respiratory muscle strength in patients with head and neck cancer receiving chemo radiation therapy: A longitudinal pilot study. F1000Research. 2022;11:294.

Santos DE dos, Rett MT, Mendonça ACR, Bezerra TS, Santana JM de, Silva Júnior WM da. Effect of radiotherapy on pulmonary function and fatigue of women undergoing treatment for breast cancer. Fisioterapia e Pesquisa. 2013;20(1):50-5.

Chauhan NS, Samuel SR, Meenar N, Saxena PUP, Keogh JWL. Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study. Peer J. 2020;8:e8617.